Authors
Loading...
Randomized trial demonstrates how engineered nanoparticle surfaces affect organ-level biodistribution, suggesting new strategies in nanomedicine.
Hou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: